Found: 10
Select item for more details and to access through your institution.
A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
- Published in:
- Mathematical Biosciences & Engineering, 2020, v. 17, n. 3, p. 2557, doi. 10.3934/mbe.2020140
- By:
- Publication type:
- Article
The benefit of anti-angiogenic therapy in EGFR exon 21 L858R mutant non-small cell lung cancer patients: a retrospective study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18889-z
- By:
- Publication type:
- Article
Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
- Published in:
- BMC Geriatrics, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12877-023-04625-3
- By:
- Publication type:
- Article
Analysis of potential genes and pathways associated with the colorectal normal mucosa–adenoma–carcinoma sequence.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 6, p. 2555, doi. 10.1002/cam4.1484
- By:
- Publication type:
- Article
The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.619010
- By:
- Publication type:
- Article
Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.
- Published in:
- Scientific Reports, 2014, v. 4, n. 1, p. N.PAG, doi. 10.1038/srep06683
- By:
- Publication type:
- Article
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06683
- By:
- Publication type:
- Article
Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-55507-6
- By:
- Publication type:
- Article
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1391972
- By:
- Publication type:
- Article